Literature DB >> 16642728

Schisandra chinensis protects against adriamycin-induced cardiotoxicity in rats.

Jyh-Sheng You1, Tai-Long Pan, Yu-Chang Hou.   

Abstract

BACKGROUND: Adriamycin (ADR) is an effective chemotherapeutic agent against cancers but its clinical use is limited due to its cardiotoxicity. It has been suggested that the pathogenesis involves inhibition of nucleic acid and protein synthesis, free radical formation and lipid peroxidation. Schisandra (SC) has strong antioxidant activity. We investigate the protective effects of SC on adriamycin-induced cardiotoxicity.
METHODS: Wistar rats were divided into four groups: CONT (control), ADR, SC and SC + ADR. After treatment, the hearts of the rats were surgically removed and studied for synthesis rates of nucleic acid and protein, myocardial antioxidants and lipid peroxidation.
RESULTS: Cardiotoxicity was characterized by ascites, congested liver and depressed cardiac function. Nucleic acid and protein synthesis were inhibited, malondialdehyde (MDA) was increased, while myocardial glutathione peroxidase (GSHPx) activity and superoxide dismutase (SOD) were decreased by ADR. In contrast, administration of SC before and concurrent with ADR significantly reduced mortality and the amount of ascites. Indexes in myocardial GSHPx, macromolecular biosynthesis and SOD activities increased with a concomitant decrease in lipid peroxidation.
CONCLUSION: These results suggest that ADR cardiotoxicity is associated with antioxidant deficit and SC treatment changes the antioxidant status of the heart and improves cardiac function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642728

Source DB:  PubMed          Journal:  Chang Gung Med J        ISSN: 2072-0939


  8 in total

1.  Protective role of deoxyschizandrin and schisantherin A against myocardial ischemia-reperfusion injury in rats.

Authors:  Ruimiao Chang; Yong Li; Xingxin Yang; Yuan Yue; Lili Dou; Yanwei Wang; Weifang Zhang; Xiaoni Li
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

2.  Extraction and Separation of Active Ingredients in Schisandra chinensis (Turcz.) Baill and the Study of their Antifungal Effects.

Authors:  Haijing Yi; Yan Chen; Jun Liu; Jie Zhang; Wei Guo; Weilie Xiao; Yuncong Yao
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

3.  α-Iso-Cubebene Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation by Suppressing Osteopontin Expression.

Authors:  Min A Jang; Seung Jin Lee; Seung Eun Baek; So Youn Park; Young Whan Choi; Chi Dae Kim
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

4.  The immuno-regulatory effects of Schisandra chinensis and its constituents on human monocytic leukemia cells.

Authors:  Rong-Dih Lin; Yi-Wen Mao; Sy-Jye Leu; Ching-Yi Huang; Mei-Hsien Lee
Journal:  Molecules       Date:  2011-06-10       Impact factor: 4.411

Review 5.  Antioxidant Effects of Schisandra chinensis Fruits and Their Active Constituents.

Authors:  Dalia M Kopustinskiene; Jurga Bernatoniene
Journal:  Antioxidants (Basel)       Date:  2021-04-18

Review 6.  The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19.

Authors:  Xuedong An; Liyun Duan; Yue Hong Zhang; Shenghui Zhao; Rong Rong Zhou; Yingying Duan; Fengmei Lian; Xiaolin Tong
Journal:  Chin Med       Date:  2021-06-07       Impact factor: 5.455

Review 7.  A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity.

Authors:  Xinyu Yang; Nian Liu; Xinye Li; Yihan Yang; Xiaofeng Wang; Linling Li; Le Jiang; Yonghong Gao; Hebin Tang; Yong Tang; Yanwei Xing; Hongcai Shang
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

8.  α-Isocubebene modulates vascular tone by inhibiting myosin light chain phosphorylation in murine thoracic aorta.

Authors:  Byeong Hyeok Ye; Eun Jung Kim; Seung Eun Baek; Young Whan Choi; So Youn Park; Chi Dae Kim
Journal:  Korean J Physiol Pharmacol       Date:  2018-06-25       Impact factor: 2.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.